126 related articles for article (PubMed ID: 7542828)
1. Tumor necrosis factor alpha but not lymphotoxin is overproduced by blood mononuclear cells in multiple sclerosis.
Głabiński A; Mirecka M; Pokoca L
Acta Neurol Scand; 1995 Apr; 91(4):276-9. PubMed ID: 7542828
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis.
Vojdani A; Vojdani E; Cooper E
J Intern Med; 2003 Oct; 254(4):363-74. PubMed ID: 12974875
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells.
Matusevicius D; Navikas V; Söderström M; Xiao BG; Haglund M; Fredrikson S; Link H
J Neuroimmunol; 1996 May; 66(1-2):115-23. PubMed ID: 8964905
[TBL] [Abstract][Full Text] [Related]
4. Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis.
Navikas V; He B; Link J; Haglund M; Söderström M; Fredrikson S; Ljungdahl A ; Höjeberg J; Qiao J; Olsson T; Link H
Brain; 1996 Feb; 119 ( Pt 1)():213-23. PubMed ID: 8624683
[TBL] [Abstract][Full Text] [Related]
5. Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission.
Hollifield RD; Harbige LS; Pham-Dinh D; Sharief MK
Autoimmunity; 2003 May; 36(3):133-41. PubMed ID: 12911279
[TBL] [Abstract][Full Text] [Related]
6. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro.
Selmaj K; Nowak Z; Tchórzewski H
Clin Exp Immunol; 1988 Jun; 72(3):428-33. PubMed ID: 2458871
[TBL] [Abstract][Full Text] [Related]
8. Autoreactive T and B cells in nervous system diseases.
Sun JB
Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
[TBL] [Abstract][Full Text] [Related]
10. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
Rohowsky-Kochan C; Molinaro D; Cook SD
Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis.
Johnson D; Hafler DA; Fallis RJ; Lees MB; Brady RO; Quarles RH; Weiner HL
J Neuroimmunol; 1986 Nov; 13(1):99-108. PubMed ID: 2428837
[TBL] [Abstract][Full Text] [Related]
12. Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis.
Sarchielli P; Orlacchio A; Vicinanza F; Pelliccioli GP; Tognoloni M; Saccardi C; Gallai V
J Neuroimmunol; 1997 Dec; 80(1-2):76-86. PubMed ID: 9413261
[TBL] [Abstract][Full Text] [Related]
13. ADAM-10 and ADAM-17 in the inflamed human CNS.
Kieseier BC; Pischel H; Neuen-Jacob E; Tourtellotte WW; Hartung HP
Glia; 2003 Jun; 42(4):398-405. PubMed ID: 12730960
[TBL] [Abstract][Full Text] [Related]
14. TNF-alpha Production by Peripheral Blood Monocytes in Multiple Sclerosis Patients and Healthy Controls.
Farrokhi M; Etemadifar M; Jafary Alavi MS; Zarkesh-Esfahani SH; Behjati M; Rezaei A; Amani-Beni A
Immunol Invest; 2015; 44(6):590-601. PubMed ID: 26207867
[TBL] [Abstract][Full Text] [Related]
15. The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis.
Zhang Y; Burger D; Saruhan G; Jeannet M; Steck AJ
Neurology; 1993 Feb; 43(2):403-7. PubMed ID: 7679782
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of cerebrospinal fluid and peripheral blood lymphocytes to myelin basic protein in multiple sclerosis.
Członkowska A; Półtorak M; Cendrowski W; Korlak J
Acta Neurol Scand; 1982 Jul; 66(1):121-9. PubMed ID: 6180592
[TBL] [Abstract][Full Text] [Related]
17. Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients.
Imamura K; Suzumura A; Hayashi F; Marunouchi T
Acta Neurol Scand; 1993 Apr; 87(4):281-5. PubMed ID: 8503256
[TBL] [Abstract][Full Text] [Related]
18. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
Zang YC; Li S; Rivera VM; Hong J; Robinson RR; Breitbach WT; Killian J; Zhang JZ
J Immunol; 2004 Apr; 172(8):5120-7. PubMed ID: 15067096
[TBL] [Abstract][Full Text] [Related]
19. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
